Abnormal accumulation of triglycerides in the liver, caused in part by increased de novo lipogenesis, results in nonalcoholic fatty liver disease and insulin resistance.Sterol regulatory element-binding protein 1 (SREBP1), an important transcriptional regulator of lipogenesis, is synthesized as an inactive precursor that binds to the endoplasmic reticulum (ER).